About Morphotek

Morphotek is one of the leading companies in the life science industry that develops novel classes of biological-based products to treat cancer, inflammation and infectious diseases. Since its founding in 2000, Morphotek has made extraordinary progress in discovering and developing monoclonal antibodies (mAbs) to treat these diseases and continues to develop additional antibody products using its proprietary technologies.

Click here to go to Morphotek's website.